-+ 0.00%
-+ 0.00%
-+ 0.00%

Novonesis signs deal to buy remaining stake in MicroBioGen

PUBT·08/10/2026 07:05:38
Listen to the news
Novonesis signs deal to buy remaining stake in MicroBioGen
  • Novozymes will acquire the remaining shares of MicroBioGen, lifting its stake from 23% to full ownership.
  • MicroBioGen is an Australian biotech focused on yeast strains for industrial use, with a core position in bioethanol.
  • The deal extends a partnership dating to Novozymes’ 2013 investment, aimed at strengthening yeast and R&D capabilities.
  • Financial terms were not disclosed; closing is subject to customary regulatory clearances, including review by Australia’s ACCC.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Novozymes A/S published the original content used to generate this news brief on August 10, 2026, and is solely responsible for the information contained therein.